Association of VEGFA promoter polymorphisms rs699947 and rs35569394 with diabetic retinopathy among North-Central Indian subjects: a case-control study

References

• Standl E, Khunti K, Hansen TB, Schnell O. The global epidemics of diabetes in the 21st century: current situation and perspectives. Eur J Prev Cardiol. 2019;26(2):7–14. doi:10.1177/2047487319881021.
   PubMed Web of Science ®Google Scholar
• Sivaprasad S, Raman R, Conroy D, Mohan WR, Rajalakshmi R, Rajalakshmi R, Majeed A, Krishnakumar S, Prevost T, and Parameswaran S, et al. The ORNATE India project: United Kingdom–India research collaboration to tackle visual impairment due to diabetic retinopathy. Eye. 2020;34:7. doi:10.1038/s41433-020-0854-8.
   Web of Science ®Google Scholar
• Balasubramanyam M, Rema M, Premanand C. Biochemical and molecular mechanisms of diabetic retinopathy. Curr Sci. 2002;83(12):1506–14.
   Web of Science ®Google Scholar
• Raman R, Gella L, Srinivasan S, and Sharma T. Diabetic retinopathy: an epidemic at home and around the world. Indian J Ophthalmol. 2016;64:69. doi:10.4103/0301-4738.178150.
   PubMed Web of Science ®Google Scholar
• Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, and Verdaguer JT, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:9. doi:10.1016/S0161-6420(03)00475-5.
   Web of Science ®Google Scholar
• Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL, Knatterud GL. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report 18. Invest Ophthalmol Vis Sci 1998;39(2):233–52.
   PubMed Web of Science ®Google Scholar
• Kollias AN, and Ulbig MW. Diabetic retinopathy: early diagnosis and effective treatment. Dtsch Arztebl Int. 2010;107(5):75–83. doi:10.3238/arztebl.2010.0075.
   PubMed Web of Science ®Google Scholar
• Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I, Jozwiak L. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol Dial Transplant. 2007;22(3):827–32. doi:10.1093/ndt/gfl641.
   PubMed Web of Science ®Google Scholar
• Murea M, Ma L, Freedman BI. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabetic Stud. 2012;9:6–22. doi:10.1900/RDS.2012.9.6.
   PubMedGoogle Scholar
• Leslie RDG, Pyke DA. Diabetic retinopathy in identical twins. Diabetes. 1982;31(1):19–21. doi:10.2337/diab.31.1.19.
   PubMed Web of Science ®Google Scholar
• Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331(22):1480–87. doi:10.1056/NEJM199412013312203.
   PubMed Web of Science ®Google Scholar
• Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962;14(4):353–62.
   PubMed Web of Science ®Google Scholar
• Moorjani P, Thangaraj K, Patterson N, Lipson M, Loh PR, Govindaraj P, Berger B, Reich D, Singh L. Genetic evidence for recent population mixture in India. Am J Hum Genet. 2013;93(3):422–38. doi:10.1016/j.ajhg.2013.07.006.
   PubMed Web of Science ®Google Scholar
• Wong TY, Klein R, Islam FMA, Cotch MF, Folsom AR, Klein BEK, Sharrett AR, Shea S. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141(3):446–55. doi:10.1016/j.ajo.2005.08.063.
   PubMed Web of Science ®Google Scholar
• Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care. 1998;21(8):1230–35. doi:10.2337/diacare.21.8.1230.
   PubMed Web of Science ®Google Scholar
• Amle D, Mir R, Khaneja A, Agarwal S, Ahlawat R, Ray PC, Saxena A. Association of 18bp insertion/deletion polymorphism, at −2549 position of VEGF gene, with diabetic nephropathy in type 2 diabetes mellitus patients of North Indian population. J Diabetes Metab Disord. 2015;14. doi:10.1186/s40200-015-0144-3
   PubMedGoogle Scholar
• Yang Q, Zhang Y, Zhang X, Li X, and Liu J. Association of VEGF gene polymorphisms with susceptibility to diabetic retinopathy: a systematic review and meta-analysis. Hormone Metab Res. 2020;52 264–279. doi:10.1055/a-1143-6024 .
   PubMed Web of Science ®Google Scholar
• Buroker N. VEGFA SNPs (rs34357231 & rs35569394), transcriptional factor binding sites and human disease. Br J Med Med Res. 2015;10:12. doi:10.9734/BJMMR/2015/19777.
   Google Scholar
• Suganthalakshmi B, Anand R, Kim R, Mahalakshmi R, Karthikprakash S, Namperumalsamy P, Sundaresan P. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis 2006;12:336–41.
   PubMed Web of Science ®Google Scholar
• Uthra S, Raman R, Mukesh BN, Rajkumar SA, Padmaja KR, Paul PG, Lakshmipathy P, Gnanamoorthy P, Sharma T, McCarty CA, et al. Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort. Ophthalmic Genet. 2008;29(1):11–15. doi:10.1080/13816810701663527.
   PubMed Web of Science ®Google Scholar
• World Health Organization W. Classification of diabetes mellitus. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. Isbn 978-92-4-151570-2. 2019.
   Google Scholar
• Shukla M, Gupta R, Pandey V, Rochette J, Dhandapany PS, Tiwari PK, and Amrathlal RS. VEGFA promoter polymorphisms rs699947 and rs35569394 are associated with the risk of anterior cruciate ligament ruptures among Indian athletes: a cross-sectional study. Orthop J Sport Med. 2020;8:12. doi:10.1177/2325967120964472.
   Web of Science ®Google Scholar
• Ahuja S, Saxena S, Akduman L, Meyer CH, Kruzliak P, Khanna VK. Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy. Int J Retin Vitr. 2019;5(1):1–6. doi:10.1186/s40942-019-0179-6.
   PubMedGoogle Scholar
• Howell WM, Ali S, Rose-Zerilli MJ, Ye S. VEGF polymorphisms and severity of atherosclerosis. J Med Genet. 2005;42(6):485–90. doi:10.1136/jmg.2004.025734.
   PubMed Web of Science ®Google Scholar
• Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK, Yeo K-T. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118(4):445–50. doi:10.1016/S0002-9394(14)75794-0.
   PubMed Web of Science ®Google Scholar
• Kapahi R, Manjari M, Uppal MS, Singh NR, Sambyal V, Guleria K. Association of - 2549 insertion/deletion polymorphism of vascular endothelial growth factor with breast cancer in North Indian patients. Genet Test Mol Biomarkers. 2013;17:242–48.doi:10.1089/gtmb.2012.0222.
   PubMed Web of Science ®Google Scholar
• Gala-Błądzińska A, Czech J, Braun M, Skrzypa M, Gargasz K, Mazur A, Zawlik I. Association of 18bp insertion/deletion polymorphism, at −2549 position of VEGF gene, with diabetic vascular complications in type 2 diabetes mellitus. Adv Med Sci. 2019;64(1):137–43. doi:10.1016/j.advms.2018.08.011.
   PubMed Web of Science ®Google Scholar
• Priščáková P, Minárik G, Repiská V. Candidate gene studies of diabetic retinopathy in human. Mol Biol Rep. 2016;43(12):1327–45. doi:10.1007/s11033-016-4075-y.
   PubMed Web of Science ®Google Scholar
• Awata T, Kurihara S, Takata N, Neda T, Iizuka H, Ohkubo T, Osaki M, Watanabe M, Nakashima Y, and Inukai K, et al. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun. 2005;333:3. doi:10.1016/j.bbrc.2005.05.167.
   Web of Science ®Google Scholar
• Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A. 1995;92(23):10457–61. doi:10.1073/pnas.92.23.10457.
   PubMed Web of Science ®Google Scholar
• Chun MY, Hwang HS, Cho HY, Chun HJ, Woo JT, Lee KW, Nam M-S, Baik S-H, Kim Y-S, Park Y, et al. Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy. J Clin Endocrinol Metab. 2010;95(7):3547–51. doi:10.1210/jc.2009-2719.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Iwasaki N, Funatsu H, Kitano S, Iwamoto Y. Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy. Graefe’s Arch Clin Exp Ophthalmol. 2009;247(1):21–26. doi:10.1007/s00417-008-0915-3.
   PubMed Web of Science ®Google Scholar
• Yang X, Deng Y, Gu H, Lim A, Altankhuyag A, Jia W, Ma K, Xu J, Zou Y, Snellingen T, et al. Polymorphisms in the vascular endothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes. Mol Vis. 2011;17:3088–96.
   PubMed Web of Science ®Google Scholar
• Abhary S, Burdon KP, Gupta A, Lake S, Selva D, Petrovsky N, Craig JE. Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy. Investig Ophthalmol Vis Sci. 2009;50(12):5552–58. doi:10.1167/iovs.09-3694.
   PubMed Web of Science ®Google Scholar
• Gong JY, Sun YH. Association of VEGF gene polymorphisms with diabetic retinopathy: a meta-analysis. PLoS One. 2013;8(12):e84069. doi:10.1371/journal.pone.0084069.
   PubMed Web of Science ®Google Scholar
• Fattah RAA, Eltanamly RM, Nabih MH, Kamal MM. Vascular endothelial growth factor gene polymorphism is not associated with diabetic retinopathy in Egyptian patients. Middle East Afr J Ophthalmol. 2016;23(1):75–78. doi:10.4103/0974-9233.171760.
   PubMed Web of Science ®Google Scholar